1,2,3,4-tetrahydro-1-phenylisoquinoline has been researched along with clopidogrel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hua, WY; Wang, FX; Wang, X; Wang, ZY; Yang, J | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydro-1-phenylisoquinoline and clopidogrel
Article | Year |
---|---|
Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Topics: Adenosine Diphosphate; Clopidogrel; Drug Design; Humans; Inhibitory Concentration 50; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Structure-Activity Relationship; Tetrahydroisoquinolines; Ticlopidine | 2004 |